Skip to main content
Caplight Logo









CynosBio, Inc.

CynosBio, Inc.

Private
TokyoEnergy & Sustainabilityhttps://cynosbio.com/

Last Round

Series C

Jul 22, 2024

Total Funding Raised

$15.03M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CynosBio, Inc. is a biotechnology company that develops, manufactures, and markets regenerative medicine products for ophthalmic and orthopedic conditions.

Sector

Energy & Sustainability

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

synthetic biologysynbiomicrobial engineeringbiomanufacturingfermentationbio-based chemicalsbioprocess engineeringstrain engineeringcellular factoriessustainable materialscontract manufacturingindustrial biotechwhite biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CynosBio, Inc. Comparables

Compare CynosBio, Inc. with similar companies based on industry and business-model similarity.

CynosBio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bacchus Bio innovation Co., Ltd.
83%
Lygos
82%
Conagen
79%

CynosBio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 22, 2024

CynosBio, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 56% MoM.

  • Jul 11, 2026

    Grew 80% QoQ from 5 to 9 employees.

CynosBio, Inc. Filings

Explore SEC and related filing metadata, where available.

CynosBio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CynosBio, Inc.'s valuation, stock price, and market status.

Is CynosBio, Inc. a public or private company?

CynosBio, Inc. is a private company.

What is the current stock price of CynosBio, Inc.?

CynosBio, Inc. is a private company with no public stock price. Caplight tracks CynosBio, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is CynosBio, Inc. worth (valuation)?

Valuation information for CynosBio, Inc. is not publicly available.

Can I buy CynosBio, Inc. stock?

CynosBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CynosBio, Inc.'s last funding round?

CynosBio, Inc.'s most recent funding round was Series C on July 22, 2024.

Who are the main investors in CynosBio, Inc.?

Key investors in CynosBio, Inc. include CEJ Capital, Axil Capital.

Will CynosBio, Inc. IPO soon?

No public IPO plans have been announced for CynosBio, Inc..

How can I track CynosBio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CynosBio, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range9
Year Founded2015
Last FundingJul 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?